Automatic Dissolution Testing with High-Temporal Resolution for Both Immediate-Release and Fixed-Combination Drug Tablets

Automatic monitoring and on-line chiral separation of chiral drug synthesis

Chiral synthesis of single chiral drugs offers high efficiency, controllable costs, and excellent enantioselectivity, making it crucial in the pharmaceutical industry. A significant number of studies on chiral drug synthesis primarily focuses on the design and synthesis of innovative chiral catalysts and ligands with extremely high selectivity, as well as the development of new methods and strategies. Nonetheless, the on-line monitoring of chiral drug synthesis and its underlying mechanisms remain obscure. The principal challenge lies in the diverse synthesis pathways and intricate mechanisms of chiral drugs, with numerous intermediates and by-products. To tackle this issue, employing the chiral drug omeprazole as a breakthrough, we design and establish a reliable and stable analytical method to monitor the synthesis process. By integrating electrokinetic chromatography technology with automatic sequence injection, the chiral synthesis of omeprazole can be comprehensively tracked and monitored throughout its entire process. During the chiral drug synthesis process, all compounds, containing all reagents and products (omeprazole sulfide, R-omeprazole, S-omeprazole, iodobenzene and iodobenzene diacetate) are efficiently separated and simultaneously detected through a single run. The method shows a high resolution greater than 1.2, a wide linear range with a detection limit as low as 0.008 μM, as well as exceptional repeatability in sequence analysis. Therefore, the proposed method has demonstrated significant value in the analysis of chiral drug synthesis and holds potential for extensive application in the industrial production of chiral compound synthesis.

Real-Time Monitoring Platform for Ocular Drug Delivery

Real-time measurement is important in modern dissolution testing to aid in parallel drug characterisation and quality control (QC). The development of a real-time monitoring platform (microfluidic system, a novel eye movement platform with temperature sensors and accelerometers and a concentration probe setup) in conjunction with an in vitro model of the human eye (PK-Eye™) is reported. The importance of surface membrane permeability when modelling the PK-Eye™ was determined with a "pursing model" (a simplified setup of the hyaloid membrane). Parallel microfluidic control of PK-Eye™ models from a single source of pressure was performed with a ratio of 1:6 (pressure source:models) demonstrating scalability and reproducibility of pressure-flow data. Pore size and exposed surface area helped obtain a physiological range of intraocular pressure (IOP) within the models, demonstrating the need to reproduce in vitro dimensions as closely as possible to the real eye. Variation of aqueous humour flow rate throughout the day was demonstrated with a developed circadian rhythm program. Capabilities of different eye movements were programmed and achieved with an in-house eye movement platform. A concentration probe recorded the real-time concentration monitoring of injected albumin-conjugated Alexa Fluor 488 (Alexa albumin), which displayed constant release profiles. These results demonstrate the possibility of real-time monitoring of a pharmaceutical model for preclinical testing of ocular formulations.

Portable and automated analyzer for rapid and high precision in vitro dissolution of drugs

We developed a novel portable and automated dissolution test analyzer for rapid and high precision in vitro dissolution testing of drugs. The analyzer consists of a flow-through-cell drug dissolution system, an automated sequential sampling system, a high-speed capillary electrophoresis (HSCE) system, and a data acquisition system. Combining the high-temporal resolution flow-gating sampling approach with HSCE, which has outstanding advantages of efficient separation and resolution, the analyzer can achieve rapid analysis and exhibits the ability in miniaturization for on-site assessment of different active pharmaceutical ingredients. To integrate the flow-through-cell dissolution system with HSCE, a specially designed flow-gating-injection (FGI) interface was employed. The performance of the analyzer was investigated by analyzing the dissolution of immediate-release drugs including single dose (amoxicillin dispersible tablets) and fixed dose combination (amoxicillin and clavulanate potassium) drug tablets with the high-temporal resolutions of 12 s and 20 s, respectively. The dissolution profiles of different active pharmaceutical ingredients could be simultaneously and automatically monitored with high repeatability and accuracy. The analyzer was successfully utilized for the pharmaceutical quality control and bio-relevant dissolution testing, as well as in vivo-in vitro correlation analysis. Our portable analyzer is miniaturized, convenient and of low-cost, and will provide a valuable tool for dissolution testing in pharmaceutical research and development.

•

Portable automated analyzer for rapid and high precision dissolution of drugs.

•

Miniaturized, low-cost and battery-powered with high repeatability and accuracy.

•

Successful applications in QC, bio-relevant dissolution and IVIVC analysis of drugs.

•

Universal applicability for both immediate-release and fixed dose combination drugs.

High-throughput monitoring of biomass conversion reaction with automatic time-resolved analysis

Reactions of biomass conversions are of great importance in fine chemistry for substantial development. While numerous studies have been performed to search for functional materials to catalyze biomass conversions, a robust and high-throughput analytical method is rather limited, which may hamper further integration and automation of the reactions. Here we propose an automatic and sequential method for the investigation of glucose conversion. By combining sequential sample injection and high-speed capillary electrophoresis (HSCE) techniques, we can monitor the glucose conversion from the beginning toward the end with a good temporal resolution. The HSCE assays are performed using short capillaries (effective length of 10 cm, i.d./o.d. of 50 μm/365 μm), and the analytes are separated at an electric field of 467 V/cm and are detected by UV-absorption at 200 nm with mixed 0.2 mM CTAB, 10 mM borate, 20 mM sorbic acid (pH 12.2) as the background electrolyte. All compounds involved in the reaction, including all products (fructose, 5-hydroxymethylfurfural, formic acid and levulinic acid) and the remaining substrate glucose, are efficiently separated and simultaneously detected from just one analysis with a temporal resolution of one minute. The method exhibits high-resolution separation, a wide linear range with limit-of-detection down to μg/mL-level, as well as excellent repeatability in sequential analysis. It is indicated that the proposed method is of great value in the analysis of complicated biomass conversion and could be potentially applied in various catalytic chemical reactions.

On-line dissolution analysis of multiple drugs encapsulated in electrospun nanofibers

Electrospun nanofiber is a very attractive material which can be used as the support to form multiple-drug dosage. Understanding the dissolution process of different active drug ingredients released from electrospun fibers is of great importance to control and evaluate the quality of medicated nanofibers. Here we present the first study of on-line automatic analysis of dissolution of multiple drugs in electrospun fiber mats. Single-needle electrospinning technology is utilized to combine polymers, hydrophilic polyvinylpyrrolidone (PVP) and hydrophobic polycaprolactone (PCL) as carrier to load three poorly water-soluble non-steroidal anti-inflammatory drugs (paracetamol, nimesulide, and ibuprofen). The loading of the drugs in PVP/PCL electrospun fibers are characterized by various techniques, including scanning electron microscopy, X-ray diffraction, Fourier infrared spectroscopy and differential scanning calorimetry. The in vitro dissolution is investigated by our home-made portable analyzer, which can simultaneously on-line determine multiple drugs released from the nanofibers by a single step. The analysis shows a wide linear detection range of the drugs with limit-of-detection (LOD) down to μg/mL-level. The dissolution profiles of three ingredients in nanofibers can be monitored every thirty seconds from the beginning to the end in the entire dissolution process from only one HSCE run. The kinetic information of the dissolution, including the dissolution curve, characteristic dissolution time and dissolution efficiency, is obtained and evaluated for different dissolution media, drug loading content and the ratio of PVP/PCL. Our study provides a promising method for rapid and accurate dissolution testing of nanofiber-based drugs, and would extend the applications of separation techniques in pharmaceutical analysis.